Metabolic methanol: molecular pathways and physiological roles

YL Dorokhov, AV Shindyapina… - Physiological …, 2015 - journals.physiology.org
Methanol has been historically considered an exogenous product that leads only to
pathological changes in the human body when consumed. However, in normal, healthy …

[HTML][HTML] Antidepressants on multiple sclerosis: a review of in vitro and in vivo models

E Stamoula, S Siafis, I Dardalas, A Ainatzoglou… - Frontiers in …, 2021 - frontiersin.org
Background Increased prevalence of depression has been observed among patients with
multiple sclerosis (MS) and correlated with the elevated levels of proinflammatory cytokines …

Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger

F Peng, Q Tao, X Wu, H Dou, S Spencer, C Mang, L Xu… - Fitoterapia, 2012 - Elsevier
Twenty-nine phenolic compounds were isolated from the root bark of fresh (Yunnan) ginger
and their structures fully characterized. Selected compounds were divided into structural …

[HTML][HTML] Tranylcypromine in mind (Part II): review of clinical pharmacology and meta-analysis of controlled studies in depression

R Ricken, S Ulrich, P Schlattmann, M Adli - European …, 2017 - Elsevier
It has been over 50 years since a review has focused exclusively on the monoamine
oxidase (MAO) inhibitor tranylcypromine (TCP). A new review has therefore been conducted …

An update on amine oxidase inhibitors: multifaceted drugs

MS Song, D Matveychuk, EM MacKenzie… - Progress in Neuro …, 2013 - Elsevier
Although not used as extensively as other antidepressants for the treatment of depression,
the monoamine oxidase (MAO) inhibitors continue to hold a niche in psychiatry and to have …

The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)

T Musgrave, C Benson, G Wong, I Browne… - Brain, behavior, and …, 2011 - Elsevier
Multiple sclerosis (MS) and the animal model, experimental autoimmune encephalomyelitis
(EAE), are both accompanied by motor and non-motor symptoms. Pathological changes in …

Monoamine oxidase inhibitors and neuroprotection: a review

SK Al-Nuaimi, EM MacKenzie… - American journal of …, 2012 - journals.lww.com
Monoamine oxidase inhibitors have been available for more than 50 years, initially
developed as antidepressants but currently used in a variety of psychiatric and neurological …

The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE)

CA Benson, G Wong, G Tenorio, GB Baker… - Behavioural brain …, 2013 - Elsevier
Many symptoms in multiple sclerosis (MS) can be related to changes in the levels of key
neurotransmitters. These neurotransmitters have a direct role in the maintenance of neurons …

Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of …

DD Mousseau, GB Baker - Current Topics in Medicinal …, 2012 - ingentaconnect.com
Historically, much of the focus on monoamine oxidases and their substrates has been in the
area of depression and the monoamine neurotransmitters serotonin (5-hydroxytryptamine) …

Azalysine analogues as probes for protein lysine deacetylation and demethylation

BCR Dancy, SA Ming, R Papazyan… - Journal of the …, 2012 - ACS Publications
Reversible lysine acetylation and methylation regulate the function of a wide variety of
proteins, including histones. Here, we have synthesized azalysine-containing peptides in …